15
Participants
Start Date
May 31, 2008
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2009
Pegylated Recombinant Human Arginase I
Week 1 (Single Dose); Weeks 3 - 11 (Weekly Dose x 8 weeks)in 8 escalation doses
Doxorubicin
Weeks 13-24 (once every 3 weeks)
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The University of Hong Kong, Hong Kong
Lead Sponsor
The University of Hong Kong
OTHER
Chinese University of Hong Kong
OTHER
Bio-Cancer Treatment International Limited
INDUSTRY